Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Treasury Shares (2020 - 2025)

Historic Treasury Shares for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $1.9 million.

  • Journey Medical's Treasury Shares fell 2362.7% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 2362.7%. This contributed to the annual value of $2.3 million for FY2024, which is 7904.35% up from last year.
  • Per Journey Medical's latest filing, its Treasury Shares stood at $1.9 million for Q3 2025, which was down 2362.7% from $2.4 million recorded in Q2 2025.
  • In the past 5 years, Journey Medical's Treasury Shares ranged from a high of $2.7 million in Q2 2024 and a low of $708524.0 during Q3 2021
  • Its 5-year average for Treasury Shares is $1.8 million, with a median of $1.9 million in 2023.
  • As far as peak fluctuations go, Journey Medical's Treasury Shares skyrocketed by 23895.66% in 2022, and later plummeted by 4312.88% in 2023.
  • Journey Medical's Treasury Shares (Quarter) stood at $715030.0 in 2021, then skyrocketed by 216.22% to $2.3 million in 2022, then tumbled by 42.2% to $1.3 million in 2023, then surged by 79.04% to $2.3 million in 2024, then dropped by 18.91% to $1.9 million in 2025.
  • Its last three reported values are $1.9 million in Q3 2025, $2.4 million for Q2 2025, and $2.3 million during Q1 2025.